Welcome
Support Centre
07 August 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Can the needs of caregivers of patients with advanced cancer be met using a general practitioner (GP) caregiver needs toolkit?
ISRCTN ISRCTN43614355
ClinicalTrials.gov identifier
Public title Can the needs of caregivers of patients with advanced cancer be met using a general practitioner (GP) caregiver needs toolkit?
Scientific title
Acronym N/A
Serial number at source 511168
Study hypothesis The number and levels of unmet needs of caregivers of patients with advanced cancer will be significantly lower in caregivers whose needs are systematically assessed using a needs assessment tool and then addressed by their general practitioner (GP), compared with caregivers receiving usual care.
Ethics approval Ethics approval received from the University of Queensland Behavioural and Social Sciences Ethical Review Committee on the 26th February 2008 (ref: 2008000206).
Study design Multi-centre randomised controlled trial
Countries of recruitment Australia
Disease/condition/study domain Advanced cancer
Participants - inclusion criteria 1. Nominated caregiver of a patient with a diagnosis of advanced cancer, i.e. no longer amenable to cure, with either extensive local or regional spread or metastatic disease
2. Aged 18 years or older, either sex
3. Able to understand English sufficiently to complete questionnaires and telephone interviews
Participants - exclusion criteria 1. Caregivers of cancer patients with a prognosis of greater than 12 months
2. Cognitively unable to give consent or unable to understand and respond to questions in English
3. Younger than 18 years of age
Anticipated start date 01/01/2009
Anticipated end date 01/10/2010
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 400, i.e. 200 per group
Interventions On recruitment, caregivers will be randomised off-site into the intervention or control group using computer-generated random number tables.

Intervention group:
The caregiver needs assessment tool (C-NAT) will be developed in the next six months. It will assess caregivers' unmet needs across a number of domains including their physical and psychological wellbeing, spiritual, existential, social, financial and legal needs, and bereavement grief. To evaluate caregivers' needs and the effectiveness of the C-NAT, participants will be surveyed using computer-assisted telephone interviews at four time-points over a six-month period: as soon as possible after recruitment, then at one month, three months and six months. We anticipate that each interview will take approximately 40 minutes. Prior to the first interview, intervention group caregivers will receive a copy of the C-NAT and the interview questions, for reference during each telephone interview. At the end of the first interview, caregivers will be asked to rate their levels of needs and to attend their GP to discuss these, preferably between one and two weeks from the interview, so that the GP can be briefed regarding the study materials. Caregivers will complete the C-NAT again after the three-month interview and visit their GP to discuss. The identified needs of intervention caregivers will be assessed and managed through a specifically developed general practice-based strategy.

Control group:
Caregivers in the control group will receive usual care, i.e. they will be surveyed regarding their needs via phone interviews only; they will have no awareness or involvement with the C-NAT nor will they be asked to visit their GP.
Primary outcome measure(s) 1. Reduced number and levels of unmet needs reported by caregivers
2. Demonstrated acceptability of the intervention for GPs

The primary outcome will be a difference of 0.9 to 1.4 units in intervention group carers' anxiety and depression scores over six months.
Secondary outcome measure(s) 1. Reduced number and levels of unmet needs reported by caregivers
2. Demonstrated acceptability of the intervention for GPs

The secondary outcomes will be the results for these measures at one month and three months.
Sources of funding National Health and Medical Research Council (NHMRC) (Australia) (ref: 51168)
Trial website
Publications
Contact name Prof  Geoffrey  Mitchell
  Address Discipline of General Practice
School of Medicine
University of Queensland
Herston Road
  City/town Herston
  Zip/Postcode 4006
  Country Australia
Sponsor National Health and Medical Research Council (NHMRC) (Australia)
  Address GPO Box 1421
  City/town Canberra ACT
  Zip/Postcode 2601
  Country Australia
  Sponsor website: http://www.nhmrc.gov.au/
Date applied 03/04/2008
Last edited 01/05/2008
Date ISRCTN assigned 01/05/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
© ISRCTN


BioMed Central